annual cash & cash equivalents:
$24.52B+$1.59B(+6.96%)Summary
- As of today (August 20, 2025), JNJ annual cash & cash equivalents is $24.52 billion, with the most recent change of +$1.59 billion (+6.96%) on December 29, 2024.
- During the last 3 years, JNJ annual cash & cash equivalents has fallen by -$7.09 billion (-22.42%).
- JNJ annual cash & cash equivalents is now -41.48% below its all-time high of $41.91 billion, reached on December 1, 2016.
Performance
JNJ Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$18.88B-$19.90B(-51.32%)Summary
- As of today (August 20, 2025), JNJ quarterly cash & cash equivalents is $18.88 billion, with the most recent change of -$19.90 billion (-51.32%) on June 30, 2025.
- Over the past year, JNJ quarterly cash & cash equivalents has dropped by -$6.59 billion (-25.89%).
- JNJ quarterly cash & cash equivalents is now -55.66% below its all-time high of $42.58 billion, reached on June 1, 2016.
Performance
JNJ quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JNJ Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | -25.9% |
| 3 y3 years | -22.4% | -42.0% |
| 5 y5 years | +27.1% | -1.3% |
JNJ Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.4% | +10.1% | -51.3% | at low |
| 5 y | 5-year | -22.4% | +27.1% | -51.3% | at low |
| alltime | all time | -41.5% | +5441.7% | -55.7% | +5552.7% |
JNJ Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $18.88B(-51.3%) |
| Mar 2025 | - | $38.78B(+58.1%) |
| Dec 2024 | $24.52B(+7.0%) | $24.52B(+20.8%) |
| Sep 2024 | - | $20.30B(-20.3%) |
| Jun 2024 | - | $25.48B(-2.8%) |
| Mar 2024 | - | $26.22B(+14.4%) |
| Dec 2023 | $22.93B(+2.9%) | $22.93B(-2.5%) |
| Sep 2023 | - | $23.51B(-17.5%) |
| Jun 2023 | - | $28.50B(-11.8%) |
| Mar 2023 | - | $32.31B(+45.0%) |
| Dec 2022 | $22.28B(-29.5%) | $22.28B(-34.6%) |
| Sep 2022 | - | $34.08B(+4.6%) |
| Jun 2022 | - | $32.57B(+7.2%) |
| Mar 2022 | - | $30.39B(-3.9%) |
| Dec 2021 | $31.61B(+25.5%) | $31.61B(+2.0%) |
| Sep 2021 | - | $31.00B(+22.5%) |
| Jun 2021 | - | $25.31B(+2.8%) |
| Mar 2021 | - | $24.62B(-2.2%) |
| Dec 2020 | $25.18B(+30.6%) | - |
| Dec 2020 | - | $25.18B(-18.2%) |
| Sep 2020 | - | $30.78B(+60.9%) |
| Jun 2020 | - | $19.14B(+6.2%) |
| Mar 2020 | - | $18.02B(-6.5%) |
| Dec 2019 | $19.29B(-2.0%) | $19.29B(+7.5%) |
| Sep 2019 | - | $17.95B(+17.5%) |
| Jun 2019 | - | $15.28B(-0.4%) |
| Mar 2019 | - | $15.34B(-22.1%) |
| Dec 2018 | $19.69B(+7.6%) | $19.69B(+1.7%) |
| Sep 2018 | - | $19.36B(+6.8%) |
| Jun 2018 | - | $18.14B(+19.3%) |
| Mar 2018 | - | $15.20B(-16.9%) |
| Dec 2017 | $18.30B(-56.3%) | $18.30B(+12.7%) |
| Sep 2017 | - | $16.23B(+26.3%) |
| Jun 2017 | - | $12.85B(-67.3%) |
| Mar 2017 | - | $39.34B(-6.1%) |
| Dec 2016 | $41.91B(+9.2%) | $41.91B(+3.6%) |
| Sep 2016 | - | $40.43B(-5.1%) |
| Jun 2016 | - | $42.58B(+6.8%) |
| Mar 2016 | - | $39.85B(+3.9%) |
| Dec 2015 | $38.38B(+16.0%) | $38.38B(+2.9%) |
| Sep 2015 | - | $37.31B(+9.9%) |
| Jun 2015 | - | $33.95B(+8.4%) |
| Mar 2015 | - | $31.32B(-5.3%) |
| Dec 2014 | $33.09B(+13.3%) | $33.09B(+0.3%) |
| Sep 2014 | - | $33.01B(+4.4%) |
| Jun 2014 | - | $31.62B(+7.6%) |
| Mar 2014 | - | $29.39B(+0.6%) |
| Dec 2013 | $29.21B(+38.5%) | $29.21B(+15.8%) |
| Sep 2013 | - | $25.23B(+0.4%) |
| Jun 2013 | - | $25.13B(+16.0%) |
| Mar 2013 | - | $21.67B(+2.7%) |
| Dec 2012 | $21.09B(-34.6%) | $21.09B(+6.7%) |
| Sep 2012 | - | $19.77B(+16.9%) |
| Jun 2012 | - | $16.91B(-50.0%) |
| Mar 2012 | - | $33.85B(+4.9%) |
| Dec 2011 | $32.26B(+16.6%) | $32.26B(+4.3%) |
| Sep 2011 | - | $30.93B(+4.2%) |
| Jun 2011 | - | $29.68B(+10.5%) |
| Mar 2011 | - | $26.87B(-2.9%) |
| Dec 2010 | $27.66B(+42.4%) | $27.66B(+25.0%) |
| Sep 2010 | - | $22.13B(+17.1%) |
| Jun 2010 | - | $18.90B(+4.9%) |
| Mar 2010 | - | $18.01B(-7.3%) |
| Dec 2009 | $19.43B(+51.7%) | $19.43B(+35.5%) |
| Sep 2009 | - | $14.34B(-2.6%) |
| Jun 2009 | - | $14.72B(+5.6%) |
| Mar 2009 | - | $13.93B(+8.8%) |
| Dec 2008 | $12.81B(+37.5%) | $12.81B(-13.4%) |
| Sep 2008 | - | $14.80B(+13.3%) |
| Jun 2008 | - | $13.06B(+17.2%) |
| Mar 2008 | - | $11.14B(+19.6%) |
| Dec 2007 | $9.31B | $9.31B(+12.0%) |
| Sep 2007 | - | $8.32B(+39.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $5.97B(+15.0%) |
| Mar 2007 | - | $5.19B(+27.1%) |
| Dec 2006 | $4.08B(-74.7%) | $4.08B(-72.2%) |
| Sep 2006 | - | $14.69B(-0.2%) |
| Jun 2006 | - | $14.72B(-14.3%) |
| Mar 2006 | - | $17.18B(+6.5%) |
| Dec 2005 | $16.14B(+25.3%) | $16.14B(+6.3%) |
| Sep 2005 | - | $15.18B(+15.3%) |
| Jun 2005 | - | $13.16B(-3.6%) |
| Mar 2005 | - | $13.65B(+5.9%) |
| Dec 2004 | $12.88B(+35.3%) | $12.88B(-1.6%) |
| Sep 2004 | - | $13.09B(+26.4%) |
| Mar 2004 | - | $10.36B(+8.8%) |
| Dec 2003 | $9.52B(+27.4%) | $9.52B(+7.6%) |
| Sep 2003 | - | $8.85B(+12.5%) |
| Jun 2003 | - | $7.86B(+0.2%) |
| Mar 2003 | - | $7.85B(+5.0%) |
| Dec 2002 | $7.47B(-6.2%) | $7.47B(+3.2%) |
| Sep 2002 | - | $7.25B(+5.7%) |
| Jun 2002 | - | $6.86B(-7.5%) |
| Mar 2002 | - | $7.41B(-7.0%) |
| Dec 2001 | $7.97B(+209.2%) | $7.97B(-2.9%) |
| Sep 2001 | - | $8.21B(+9.2%) |
| Jun 2001 | - | $7.52B(+27.4%) |
| Mar 2001 | - | $5.90B(+5.6%) |
| Sep 2000 | - | $5.59B(+24.2%) |
| Jun 2000 | - | $4.50B(+25.2%) |
| Sep 1999 | - | $3.59B(+26.7%) |
| Jun 1999 | - | $2.83B(+10.0%) |
| Dec 1998 | $2.58B(-11.1%) | $2.58B(-32.6%) |
| Sep 1998 | - | $3.83B(+18.5%) |
| Jun 1998 | - | $3.23B(+6.9%) |
| Mar 1998 | - | $3.02B(+4.2%) |
| Dec 1997 | $2.90B(+35.7%) | $2.90B(-7.0%) |
| Sep 1997 | - | $3.12B(+31.9%) |
| Jun 1997 | - | $2.36B(+2.6%) |
| Mar 1997 | - | $2.30B(+7.9%) |
| Dec 1996 | $2.14B(+56.6%) | $2.14B(-3.9%) |
| Sep 1996 | - | $2.22B(+13.5%) |
| Jun 1996 | - | $1.96B(+5.1%) |
| Mar 1996 | - | $1.86B(+55.1%) |
| Dec 1995 | $1.36B(+106.7%) | $1.20B(-7.1%) |
| Sep 1995 | - | $1.29B(+24.2%) |
| Jun 1995 | - | $1.04B(+126.3%) |
| Mar 1995 | - | $460.00M(-27.7%) |
| Dec 1994 | - | $636.00M(-26.6%) |
| Sep 1994 | - | $866.00M(+51.7%) |
| Jun 1994 | - | $571.00M(+71.0%) |
| Mar 1994 | - | $334.00M(-10.2%) |
| Dec 1993 | - | $372.00M(-42.2%) |
| Sep 1993 | - | $644.00M(+8.2%) |
| Jun 1993 | - | $595.00M(+21.9%) |
| Mar 1993 | - | $488.00M(-34.5%) |
| Dec 1992 | - | $745.00M(+9.4%) |
| Sep 1992 | - | $681.00M(+50.7%) |
| Jun 1992 | - | $452.00M(+14.7%) |
| Mar 1992 | - | $394.00M(-33.1%) |
| Dec 1991 | - | $589.00M(+1.7%) |
| Sep 1991 | - | $579.00M(+5.7%) |
| Jun 1991 | - | $548.00M(+24.5%) |
| Mar 1991 | - | $440.00M(-46.7%) |
| Dec 1990 | - | $826.00M(-2.2%) |
| Sep 1990 | - | $845.00M(+32.9%) |
| Jun 1990 | - | $636.00M(+15.8%) |
| Mar 1990 | - | $549.00M(+21.5%) |
| Dec 1989 | - | $452.00M(+2.3%) |
| Sep 1989 | - | $442.00M(+7.8%) |
| Mar 1989 | - | $410.00M(-37.9%) |
| Dec 1988 | $660.00M(-10.9%) | $660.00M(-10.9%) |
| Dec 1987 | $741.00M(-22.2%) | $741.00M(-22.2%) |
| Dec 1986 | $952.50M(+29.5%) | $952.50M(+29.5%) |
| Dec 1985 | $735.60M(+66.2%) | $735.60M(+66.2%) |
| Dec 1984 | $442.50M | $442.50M |
FAQ
- What is Johnson & Johnson annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Johnson & Johnson?
- What is Johnson & Johnson annual cash & cash equivalents year-on-year change?
- What is Johnson & Johnson quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Johnson & Johnson?
- What is Johnson & Johnson quarterly cash & cash equivalents year-on-year change?
What is Johnson & Johnson annual cash & cash equivalents?
The current annual cash & cash equivalents of JNJ is $24.52B
What is the all time high annual cash & cash equivalents for Johnson & Johnson?
Johnson & Johnson all-time high annual cash & cash equivalents is $41.91B
What is Johnson & Johnson annual cash & cash equivalents year-on-year change?
Over the past year, JNJ annual cash & cash equivalents has changed by +$1.59B (+6.96%)
What is Johnson & Johnson quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of JNJ is $18.88B
What is the all time high quarterly cash & cash equivalents for Johnson & Johnson?
Johnson & Johnson all-time high quarterly cash & cash equivalents is $42.58B
What is Johnson & Johnson quarterly cash & cash equivalents year-on-year change?
Over the past year, JNJ quarterly cash & cash equivalents has changed by -$6.59B (-25.89%)